Skip to the page

Data / Form D filings / Nok Therapeutics, Inc.

Nok Therapeutics, Inc.: Form D filings

Nok Therapeutics, Inc., a biotechnology company in Cranberry Twp., PA, filed 8 Form D notices with the SEC between 2025 and 2026. The latest, on May 1, 2026, reports $750,500 sold of an offering with no set size to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2009 MACKENZIE WAY SUITE 100, Cranberry Twp., PA, 16066
Phone
(888) 691-5839
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Florida
Year incorporated
2024
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2038166

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 1, 2026AmendmentIndefinite$750,5005Sep 24, 2024sec.gov
May 1, 2026Amendment$3,200$3,20014Jun 11, 2024sec.gov
Apr 22, 2026Amendment$1,400$1,4009Jun 27, 2024sec.gov
Apr 22, 2026AmendmentIndefinite$500,5004Oct 8, 2024sec.gov
Apr 22, 2026Amendment$750,000$649,000$101,00017Aug 6, 2024sec.gov
Mar 26, 2026New notice$1,400$1,4009Jun 27, 2024sec.gov
Oct 24, 2025New noticeIndefinite$250,5003Oct 8, 2024sec.gov
Oct 24, 2025New notice$750,000$566,500$183,50017Aug 6, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Robert LewisExecutive Officer, Director, PromoterNo family relationship with Martin Lewis or Michael Lewis
Brian CogleyExecutive Officer, Director
Bruce CassidyDirector
Martin LewisDirectorNo family relationship with Michael Lewis or Robert Lewis
Michael LewisPromoterNo family relationship with Martin Lewis or Robert Lewis
David MehalickPromoter

Other biotechnology companies in Pennsylvania that filed recently

Every Form D from the week of Apr 27, 2026 · All recent filings in Pennsylvania · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Nok Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.